>>Description of the research protocol

Cross-sectional survey to collect treatment experience feedback from patients, physicians, nurses and carers after switching to paliperidone palmitate 3-monthly
Status : Ongoing and recruiting

Additional details

Indication (or studied pathology) : Psychiatrie
EudraCT identifier : B077201838036
ClinicalTrials.gov identifier : NCT03809325


Involved department : Psychiatry
Principal investigator : Kornreich/Steegen
Sponsor : Janssen-Cilag NV
Contact : Clinical Research Unit

>This protocol was approved by the Brugmann (CE Central) ethics committee.